Purple Biotech Ltd. (PPBT)

Purple Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	12	15	25	68	7	12
Market Cap Growth	-48.89%	-37.05%	-63.80%	810.87%	-40.28%	68.51%
Enterprise Value	1	0	-7	21	-49	6
PE Ratio	-	0.78	1.13	3.69	0.27	2.13
PB Ratio	0.37	0.45	0.52	1.05	0.09	1.20
P/FCF Ratio	-0.89	-0.78	-1.45	-4.42	-0.61	-2.23
P/OCF Ratio	-0.89	-0.78	-1.47	-4.45	-0.62	-2.24
EV/EBITDA Ratio	0.05	0.02	-0.32	1.14	-1.75	0.98
EV/EBIT Ratio	0.05	0.02	-0.32	1.15	-1.76	1.01
EV/FCF Ratio	-0.34	-0.02	0.41	-1.40	4.04	-1.13
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.01	0.02
Debt / EBITDA Ratio	0.01	0.02	0.02	0.04	0.03	0.03
Debt / FCF Ratio	-0.02	-0.02	-0.03	-0.05	-0.07	-0.04
Quick Ratio	1.28	1.59	4.55	11.11	18.82	1.80
Current Ratio	1.34	1.63	4.71	11.41	19.14	2.34
Interest Coverage	9.27	10.06	324.40	87.72	460.00	34.51
Return on Equity (ROE)	51.30%	49.00%	40.80%	26.20%	62.40%	55.90%
Return on Assets (ROA)	42.30%	41.70%	35.90%	24.30%	56.80%	39.70%
Return on Capital (ROIC)	-69.00%	-64.45%	-47.66%	-27.35%	-16.49%	-60.44%
Earnings Yield	162.84%	128.47%	88.15%	27.08%	375.62%	46.87%
FCF Yield	-164.40%	-128.78%	-69.01%	-22.63%	-164.31%	-44.80%
Buyback Yield / Dilution	-36.56%	-11.37%	-913.93%	-52.76%	-493.78%	-36.34%
Total Shareholder Return	-36.56%	-11.37%	-913.93%	-52.76%	-493.78%	-36.34%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).